DARE

Dare Bioscience Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↑ 7/10
  • Value↓ 0/10
Dare Bioscience sales and earnings growth
DARE Growth
Good
  • Revenue Y/Y↑ 2615.07%
  • EPS Y/Y↓ -464.71%
  • FCF Y/Y↓ -266.82%
Dare Bioscience gross and profit margin trends
DARE Profitability
Good
  • Gross margin ↑ 53.50%
  • EPS margin↓ -1038.80%
  • ROIC 5Y↑ 147.10%
Dare Bioscience net debt vs free cash flow
DARE Risk
Great
  • Debt / Equity↑ 2.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Dare Bioscience stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks